Biotron Ltd (BIT) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.322x

Based on the latest financial reports, Biotron Ltd (BIT) has a cash flow conversion efficiency ratio of -0.322x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-868.42K ≈ $-614.46K USD) by net assets (AU$2.70 Million ≈ $1.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Biotron Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Biotron Ltd - Cash Flow Conversion Efficiency Trend (2001–2026)

This chart illustrates how Biotron Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Biotron Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biotron Ltd ranked by their cash flow conversion efficiency. Explore earnings quality score of Biotron Ltd to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Soco Corporation Ltd
AU:SOC
-0.288x
TAIZHOU WATER GRP. H YC 1
F:GX5
N/A
Kane Biotech Inc
V:KNE
0.912x
Euroespes S.A.
MC:EEP
0.003x
DOREL INDS INC. A
F:DO4C
-0.047x
International Lithium Corp
V:ILC
-0.028x
Inix Technologies Holdings Bhd
KLSE:0094
0.015x
Autonomix Medical, Inc. Common Stock
NASDAQ:AMIX
-1.121x

Annual Cash Flow Conversion Efficiency for Biotron Ltd (2001–2026)

The table below shows the annual cash flow conversion efficiency of Biotron Ltd from 2001 to 2026. View Biotron Ltd stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-06-30 AU$2.92 Million
≈ $2.07 Million
AU$-1.78 Million
≈ $-1.26 Million
-0.608x +40.67%
2025-06-30 AU$551.89K
≈ $390.50K
AU$-565.80K
≈ $-400.34K
-1.025x -107.01%
2024-06-30 AU$-244.03K
≈ $-172.67K
AU$-3.57 Million
≈ $-2.52 Million
14.623x +1510.16%
2023-06-30 AU$3.17 Million
≈ $2.24 Million
AU$-3.29 Million
≈ $-2.33 Million
-1.037x +53.49%
2022-06-30 AU$1.09 Million
≈ $773.01K
AU$-2.44 Million
≈ $-1.72 Million
-2.230x -152.78%
2021-06-30 AU$3.86 Million
≈ $2.73 Million
AU$-3.41 Million
≈ $-2.41 Million
-0.882x -99.59%
2020-06-30 AU$6.97 Million
≈ $4.93 Million
AU$-3.08 Million
≈ $-2.18 Million
-0.442x -60.48%
2019-06-30 AU$5.44 Million
≈ $3.85 Million
AU$-1.50 Million
≈ $-1.06 Million
-0.275x +80.84%
2018-06-30 AU$1.28 Million
≈ $906.75K
AU$-1.84 Million
≈ $-1.30 Million
-1.437x +26.95%
2017-06-30 AU$1.44 Million
≈ $1.02 Million
AU$-2.83 Million
≈ $-2.00 Million
-1.968x -100.34%
2016-06-30 AU$3.14 Million
≈ $2.22 Million
AU$-3.08 Million
≈ $-2.18 Million
-0.982x -49.61%
2015-06-30 AU$4.14 Million
≈ $2.93 Million
AU$-2.72 Million
≈ $-1.92 Million
-0.656x +69.35%
2014-06-30 AU$1.39 Million
≈ $983.02K
AU$-2.98 Million
≈ $-2.11 Million
-2.142x -210.15%
2013-06-30 AU$4.48 Million
≈ $3.17 Million
AU$-3.09 Million
≈ $-2.19 Million
-0.691x -149.63%
2012-06-30 AU$8.27 Million
≈ $5.85 Million
AU$-2.29 Million
≈ $-1.62 Million
-0.277x +66.27%
2011-06-30 AU$2.40 Million
≈ $1.70 Million
AU$-1.97 Million
≈ $-1.39 Million
-0.820x +24.19%
2010-06-30 AU$1.72 Million
≈ $1.22 Million
AU$-1.86 Million
≈ $-1.31 Million
-1.082x +51.88%
2009-06-30 AU$841.51K
≈ $595.42K
AU$-1.89 Million
≈ $-1.34 Million
-2.249x -155.50%
2008-06-30 AU$1.84 Million
≈ $1.30 Million
AU$-1.62 Million
≈ $-1.15 Million
-0.880x +67.26%
2007-06-30 AU$1.36 Million
≈ $959.47K
AU$-3.65 Million
≈ $-2.58 Million
-2.688x -576.13%
2006-06-30 AU$4.50 Million
≈ $3.18 Million
AU$-1.79 Million
≈ $-1.26 Million
-0.398x +47.04%
2005-06-30 AU$2.28 Million
≈ $1.61 Million
AU$-1.71 Million
≈ $-1.21 Million
-0.751x +14.84%
2004-06-30 AU$2.96 Million
≈ $2.09 Million
AU$-2.61 Million
≈ $-1.84 Million
-0.882x -344.86%
2002-06-30 AU$8.49 Million
≈ $6.01 Million
AU$-1.68 Million
≈ $-1.19 Million
-0.198x -52.42%
2001-06-30 AU$10.08 Million
≈ $7.13 Million
AU$-1.31 Million
≈ $-927.34K
-0.130x --

About Biotron Ltd

AU:BIT Australia Biotechnology
Market Cap
$3.94 Million
AU$5.57 Million AUD
Market Cap Rank
#29131 Global
#1608 in Australia
Share Price
AU$0.00
Change (1 day)
+0.00%
52-Week Range
AU$0.00 - AU$0.01
All Time High
AU$0.30
About

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225 that is in Phase 2 clinical trial for the treatment of HIV-1, as well as to treat hepatitis C virus infections; and BIT-HBV001 to treat hepatitis B virus and hepatitis delta virus. It also develops pre… Read more